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Evidence for elevated pulse pressure in patients on chronic Several studies have shown that pulse pressure (PP)
hemodialysis: A case-control study. is an independent risk factor for cardiovascular events
Background. Few analyses have compared pulse pressure in the general population [1, 2]. PP is potent indicator(PP) values in hemodialysis patients with healthy individuals,
of cardiovascular death [3] and an independent predictorand they have provided only limited data. We retrospectively
of risk of mortality [4, 5] in chronic hemodialysis patients.examined PP in a large cohort of hemodialysis patients and
healthy control subjects. Recent reports suggest that the relationship between PP
Methods. The relationships of systolic blood pressure (SBP), and atherosclerosis is bi-directional in that elevated PP
diastolic blood pressure (DBP), and PP to mean arterial pres- is both a cause and a consequence of atherosclerosis [6].sure (MAP) levels were investigated in 234 chronic hemodialy-
This finding led us to hypothesize that PP in hemodialysissis patients and in 682 control subjects matched for age, sex,
patients is higher than that in non-uremic subjects. Sincediabetes mellitus, and body mass index.
Results. In both control and patients, PP was positively cor- data concerning the difference in PP between hemodialy-
related with MAP, and the two regression lines were parallel sis patients and subjects with normal renal function are
(beta of control subjects 0.52; beta of hemodialysis patients limited, we conducted the present retrospective, case-0.57, P  0.48). According to the regression line, at any MAP
control study to determine whether PP in hemodialysislevel, the PP in hemodialysis patients was significantly higher
patients is higher than that in subjects with normal renalthan that in control subjects: the mean PP difference between
control and patients was 19.2 mm Hg (95% CI, 17.2 to 21.1 function.
mm Hg, P  0.0001). When the relationships between MAP
and SBP and that between MAP and DBP were analyzed, the
regression lines were also parallel. However, at any MAP level, METHODS
SBP was higher and DBP was lower in hemodialysis patients
Hemodialysis patientsthan control subjects; the mean SBP difference was 12.8 mm Hg
(95% CI, 11.5 to 14.1 mm Hg, P  0.0001) and mean DBP dif- Chronic hemodialysis patients in seven dialysis centers
ference was 6.4 mm Hg (95% CI, 5.7 to 7.0 mm Hg, P  selected from those participating in the Okinawa Dialysis
0.0001).
Study (OKIDS) were surveyed [7]. The data of 850 pa-Conclusions. At any MAP level, hemodialysis patients had
tients (489 men, 361 women) who were alive on August 1,a higher SBP, lower DBP, and higher PP values than those con-
trol subjects with a normal renal function who were matched 1999, were examined cross-sectionally. The average group
for age, sex, diabetes mellitus, and body mass index. Further size per center was 121 patients (range 25 to 233). Pa-
study is needed to determine whether preventing or reducing an tients with end-stage renal disease who survived at leastelevated PP improves the prognosis for hemodialysis patients.
one month of dialysis were registered as chronic dialysis
patients. Clinical data were obtained by reviewing medi-
cal records in each dialysis unit. The dialysis sessions
occurred two or three times per week per patient for 3.5
to 4.0 hours per session. Bicarbonate solution was usedKey words: systolic blood pressure, diastolic blood pressure, pulse pres-
as the dialysate in all patients (note that re-use of asure, mean pressure, hemodialysis, end-stage renal disease, case-con-
trol study. dialyzer is the exception in Japan). Baseline data of labo-
ratory and clinical variables were obtained immediatelyReceived for publication April 10, 2002
before the first routine hemodialysis session of the weekand in revised form May 29, 2002
Accepted for publication July 11, 2002 in August 1999. Similarly, baseline systolic blood pres-
sure (SBP) and diastolic blood pressure (DBP) were re- 2002 by the International Society of Nephrology
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Table 1. Characteristics of hemodialysis and control subjectscorded to establish blood pressure status pre-dialysis [8]:
BP data were taken immediately before the first routine Control Hemodialysis
subjects patientshemodialysis session of the week in August 1999 by
Parameter N  682 N  234 Ptrained nurses or the paramedic staff using a sphygmo-
Age years 5412 5514 0.47manometer. Of the 850 hemodialysis patients, 602 pa-
Men % 61 61 0.94
tients taking antihypertensive medication at the time of Diabetes mellitus % 20 20 0.99
Body mass index kg/m2 23.13.4 23.03.6 0.82the examination and 10 patients whose data were not
Hematocrit % 42.13.8 30.83.6 0.0001available were excluded from the study. Among the re-
Total cholesterol mg/dL 20736 16135 0.0001
maining 238 patients, four who had angina pectoris or Serum creatinine mg/dL 0.960.15 12.73.1 0.0001
Hemodialysis duration months — 9469 —history of myocardial infarction were excluded. Finally,
SBP mm Hg 12218 15419 0.0001the data of 234 hemodialysis patients were evaluated in
DBP mm Hg 7411 7911 0.0001
the present study. PP mm Hg 4912 7517 0.0001
MAP mm Hg 9012 10412 0.0001
Control subjects Data are expressed as mean  SD. Abbreviations are: SBP, systolic blood
pressure; DBP, diastolic blood pressure; PP, pulse pressure; MAP, mean arterialThe control subjects in the present study participated
pressure. The body mass index is the weight in kilograms divided by the square
in a screening program, the data from which have been of the height in meters.
reported previously [9, 10]. The screening was a one-
day clinic program run by the Okinawa General Health
Maintenance Association, and involved a thorough phys-
serum creatinine, and duration of hemodialysis as inde-ical examination. In the morning after the patient had
pendent variables. StatView 5.0 software (SAS Institute,been sitting for 15 minutes, blood pressure was measured
Cary, NC, USA) was used for data analysis. A P valueby a trained nurse. About 10,000 adults presently partici-
0.05 was considered significant.pate each year in the screening program. Among 9914
subjects screened in 1997, 8419 had normal renal function
(serum creatinine 1.2 mg/dL in men, 1.0 mg/dL in RESULTS
women) and negative proteinuria by dipstick examina-
Characteristics of the study subjectstion. We excluded subjects who were treated with antihy-
Age, percentage of men, diabetes mellitus, and bodypertensive agents, had a history of cardiovascular dis-
mass index were not significantly different between con-ease, or received a treatment for cardiovascular disease.
trol subjects and hemodialysis patients (Table 1). Hemo-Among the 7680 individuals not excluded by these crite-
dialysis patients had lower hematocrit and serum choles-ria, subjects were randomly selected who were matched
terol level, and higher serum creatinine level, SBP, DBP,for age, sex, diabetes mellitus, and body mass index with
PP, and MAP than those of control subjects. The preva-the patient group at a case:control ratio of 1:2. Finally,
lence of lipid lowering therapy in hemodialysis patientsa total of 682 normal controls were selected for analysis
was significantly higher (P  0.0001): the number ofin the present study.
hemodialysis patients on the treatment was 16 (6.8%)
Definition of clinical factors and that of control subjects was 4 (0.6%).
Hypertension was considered present in patients with
Relation of pulse pressure to ageSBP 140 mm Hg, or DBP 90 mm Hg at the time of
When the data for control subjects and hemodialysisexamination. In screened control subjects, diabetes melli-
patients were independently plotted with age as the x-axistus was diagnosed if fasting blood glucose level was 126
and PP as the y-axis (Fig. 1), the beta coefficients ofmg/dL (7 mmol/L) [11], hemoglobin A1c (Hb A1c) was
regression lines in control subjects (  0.43, y cut-off7.0%, or the subject was under diabetes mellitus ther-
level  25.3, r 2  0.19, P  0.0001) and hemodialysisapy. Diabetes mellitus in hemodialysis patients was diag-
patients (  0.25, y cut-off level  61.5, r 2  0.04, P nosed as the cause of end-stage renal disease. PP was
0.001) were significantly different (P  0.009); the y cut-calculated as SBPDBP. Mean arterial pressure (MAP)
off levels of the two lines were significantly differentwas calculated as DBP 	 (SBP  DBP)/3.
(P  0.0001). At any age, hemodialysis patients had a
Statistical analysis higher PP than that of control subjects; however, increase
of PP per year of age was less in hemodialysis patientsThe unpaired t test or the chi-squared test was used
than in control subjects.to analyze differences in values or ratios between pa-
tients and control subjects. The relationships of PP, SBP,
Relationship of pulse pressure to mean arterial pressureand DBP to MAP were estimated by regression analysis.
When the data for control subjects and hemodialysisMultiple regression analysis for PP was done with age,
sex, diabetes mellitus, body mass index, total cholesterol, patients were independently plotted with MAP as the
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Fig. 1. Relationship between age and pulse pressure in control subjects (A) and chronic hemodialysis patients (B). The regression lines for both
groups are included in each panel so that the parallel relation of the lines is apparent. Lines represent: (gray) regression line of normal control;
(black) regression line of dialysis patients.
Fig. 2. Relationship between mean arterial pressure and pulse pressure in control subjects (A) and chronic hemodialysis patients (B). The
regression lines for both groups are included in each panel so that the parallel relation of the lines is apparent. Lines represent: (gray) regression
line of normal control; (black) regression line of dialysis patients.
x-axis and PP as the y-axis the beta coefficients of regres- x-axis and SBP as the y-axis, the beta coefficients of regres-
sion lines in control subjects (  1.3, y cut-off level sion lines in control subjects (  0.52, y cut-off level 
2.2, r 2  0.27, P  0.0001) and hemodialysis patients 1.4, r 2  0.84, P 0.0001) and hemodialysis patients (
1.3, y cut-off level10.6, r 2  0.70, P  0.0001) were not(  0.57, y cut-off level  15.9, r 2  0.15, P  0.0001)
were not significantly different (P  0.48; Fig. 2). How- significantly different (P  0.48; Fig. 3). However, the
y-cut-off levels of the two lines were significantly differ-ever, the y cut-off levels of the two lines were significantly
different (P  0.0001), that is, at any MAP level the ent (P 0.0001), that is, at any MAP level, hemodialysis
patients had a higher SBP value than that of the controlhemodialysis patients had a higher PP than that of con-
trol subjects. Under this condition, the beta coefficient subjects. Under this condition, the beta coefficient of the
common regression line in control subjects and hemodi-of the common regression line in control subjects and
hemodialysis patients was calculated as 0.53. For these alysis patients was calculated as 1.36. For these two paral-
lel regression lines, the mean difference of SBP was 12.8two parallel regression lines, the mean difference of PP
was 19.2 mm Hg (95% CI, 17.1 to 21.1, P  0.0001). mm Hg (95% CI, 11.5 to 14.1, P  0.0001).
Relationship of diastolic blood pressure to meanRelationship of systolic blood pressure to mean
arterial pressure arterial pressure
Data for the control subjects and hemodialysis patientsWhen the data for control subjects and hemodialysis
patients were independently plotted with MAP as the were independently plotted with MAP as the x-axis and
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Fig. 3. Relationship between mean arterial pressure and systolic blood pressure in control subjects (A) and chronic hemodialysis patients (B).
The regression lines for both groups are included in each panel so that the parallel relation of the lines is apparent. Lines represent: (gray)
regression line of normal control; (black) regression line of dialysis patients.
Fig. 4. Relationship between mean arterial pressure and diastolic pressure in control subjects (A) and chronic hemodialysis patients (B). The
regression lines for both groups are included in each panel so that the parallel relation of the lines is apparent. Lines represent: (gray) regression
line of normal control; (black) regression line of dialysis patients.
DBP as the y-axis (Fig. 4). Beta coefficient of regression a multiple linear regression analysis was performed with
lines in control subjects (  0.83, y cut-off level0.7, PP as the dependent variable (Table 2). Independent
r 2  0.89, P  0.0001) and hemodialysis patients (  variables included in the analysis are presented in Ta-
0.81, y cut-off level  5.3, r 2  0.77, P  0.0001) were ble 2. In both control subjects and hemodialysis patients,
not different (P  0.48). However, the y cut-off levels age and diabetes mellitus were significant predictors of
of the two lines were significantly different (P 0.0001). PP. Body mass index was also a significant predictor of
At any MAP level, hemodialysis patients had a lower PP in control subjects.
DBP than that of control subjects. Under this condition,
the beta coefficient of the common regression line in
DISCUSSIONcontrol subjects and hemodialysis patients was calculated
Mortality rates of hemodialysis patients were higheras 0.82. For these two parallel regression lines, the mean
than that of the general population. Although the cardiacdifference of DBP was 6.4 mm Hg (95% CI, 5.7 to 7.0,
death rate has decreased significantly over past threeP  0.0001).
decades, cardiac events remain a leading cause of death
Correlations between clinical variables and pulse in hemodialysis patients [12]. Investigators have reported
pressure in control subjects and hemodialysis patients that higher PP is a risk factor for cardiovascular events
and mortality in the general population [1, 2] and hemo-To analyze which clinical variables in the control sub-
jects and hemodialysis patients are associated with PP, dialysis patients [3–5]. However, these previous reports
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Table 2. Multiple regression analysis of clinical characteristics cant risk for cardiovascular event or all-cause mortality.
related to pulse pressure as a dependent variable
Benetos et al investigated 19,083 men for mean 19.5
Independent variables  t P years and reported that PP (10 mm Hg) was a significant
Control subjectsa predictor of all-case mortality in young (OR; 95% CI:
Age years 0.40 11.7 0.0001 1.28; 1.22 to 1.35) and older (1.19; 1.14 to 1.23) subjects
Sex (men  1, women  0) 0.15 0.11 0.91
[1]. In the Framingham Heart study, Franklin et al stud-Diabetes mellitus (yes  1, no  0) 4.9 4.6 0.0001
Body mass index kg/m2 0.30 2.4 0.01 ied 1924 men and women over a 20-year follow-up and
Hematocrit % 0.02 2.3 0.85 reported that PP (10 mm Hg) was a significant risk for
Total cholesterol mg/dL 0.01 0.87 0.38
coronary heart disease: hazard ratio (95% CI)  1.23Serum creatinine mg/dL 2.07 0.54 0.58
Hemodialysis patientsb (1.16 to 1.30) [2]. In hemodialysis patients, Amar et al
Age years 0.27 3.0 0.002 used 24-hour ambulatory BP recordings and showed that
Sex (men  1, women  0) 0.41 0.16 0.88
PP (10 mm Hg) was a predictor of cardiovascular deathDiabetes mellitus (yes  1, no  0) 8.6 2.8 0.005
Body mass index kg/m2 0.26 0.82 0.42 in 57 treated hypertensive hemodialysis patients [3]. We
Hematocrit % 0.05 0.18 0.86 investigated 1243 hemodialysis patients for nine years
Total cholesterol mg/dL 0.003 0.09 0.93
and reported that PP (10 mm Hg) predicted a mortal-Serum creatinine mg/dL 0.39 0.81 0.41
Hemodialysis duration months 0.01 0.56 0.57 ity:hazard ratio (95% CI) of 1.080 (1.030 to 1.137) [4],
while Klassen et al analyzed data from 37,069 hemodialy-a R 2  0.24, F  30.1, P  0.0001
b R 2  0.09, F  2.8, P  0.005 sis patients for about one year and found that the hazard
of death:hazard ratio (95% CI) increased by 12% to 1.12
(1.06 to 1.18) in post-dialysis PP (10 mm Hg). The present
study found a substantial difference in PP between he-did not clarify whether pulse pressure in hemodialysis
modialysis patients and control subjects. The relation-patients is wider than that of control subjects with normal
ship between PP and mortality was dose-dependent inrenal function. To our knowledge, the present study is
both the general population [1, 2] and hemodialysis pa-the first to show that PP in hemodialysis patients is larger
tients [4, 5]. Taken together, this evidence suggests thatthan that in control subjects with normal renal function
the difference in PP can contribute to the difference in
who were matched for age, sex, diabetes mellitus, and
mortality rate between hemodialysis patients and the
body mass index. London et al reported that PP in hemo- general population.
dialysis patients (N 92) was higher than that in control The normal and the reference values of PP were not
subjects (N  90) (76.6  23.7 vs. 63.9  22 mm Hg, P reported in any study except that of Asmar et al [14].
0.007) despite a similar MAP between the two groups These authors showed that 50 mm Hg was likely the
(110.2  17.2 mm Hg for hemodialysis patients and reference value for PP in 61,724 ambulatory unselected
109.9 19.3 mm Hg for control subjects, NS) [13]. How- subjects in France. Their value is similar to the PP value
ever, their case-control study involved relatively few pa- in our control subjects (49 mm Hg).
tients and controls for whom body mass-mass index was Pulse pressure was elevated in hemodialysis patients
not matched, and the PP in their control subjects was compared with control subjects in the present study. In-
relatively high compared with the reference value reported creased PP was a significant predictor of risk of mortality
recently in France (63.9 vs. 50 mm Hg) [14]. in hemodialysis patients [3–5]. However, the effect of PP
Our results extend those of prior reports in several reduction on the prognosis for hemodialysis patients re-
aspects. In hemodialysis patients, age, diabetes mellitus mains to be determined, and thus it is too soon to con-
and body mass index have been reported as significantly sider PP reduction as a therapeutic target in the treat-
associated with PP level [4]. Therefore, when we selected ment of hemodialysis patients. If such reduction is finally
control subjects, age, sex, diabetes mellitus, and body indicated, there are a few approaches for decreasing PP.
mass index were matched to hemodialysis patients, and First, treatment of elevated SBP would effectively reduce
then control subjects were randomly selected from the PP because high SBP contributes more to an elevated PP
matched group. PP increased with the elevation of MAP than low DBP [4] and because PP is correlated with MAP
[6]. We analyzed the data for the relationships of MAP [6]. Second, arterial compliance should be taken into
to PP, SBP, and DBP to compare blood pressure compo- account. Recovering the compliance leads to decreased
nents in hemodialysis patients to those in control sub- PP. Reports have noted that aerobic physical exercise
jects. Finally, we calculated the mean of PP difference [15], fish oil [16], soy isoflavones [17] and salt restriction
and 95% CI between the regression line of hemodialysis [18] could augment arterial compliance. Among antihy-
patients and that of control subjects. pertensive agents, angiotensin-converting enzyme inhib-
Although the outcome of all subjects was not deter- itor [19, 20] and calcium channel blocker [21, 22] reduce
mined in the present study, there is some epidemiological the aortic pulse wave velocity, which is an index of arte-
rial compliance.evidence suggesting that a broader PP value is a signifi-
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and 24-hour pulse pressure are potent indicators of mortality inThe effects of increased PP and atherosclerosis may
hemodialysis patients. Kidney Int 57:2485–2491, 2000
constitute a feedback loop. Arterial stiffening increases 4. Tozawa M, Iseki K, Iseki C, et al: Pulse pressure and risk of
PP [6], and PP elevation induces endothelial dysfunction total mortality and cardiovascular events in patients on chronic
hemodialysis. Kidney Int 61:717–726, 2002[23]. Effect on endothelial pH of pulsatile perfusion is
5. Klassen PS, Lowrie EG, Reddan DN, et al: Association betweendifferent from that of steady shear stress [24]. Further pulse pressure and mortality in patients undergoing maintenance
study is needed to elucidate the role of PP in the patho- hemodialysis. JAMA 287:1548–1555, 2002
6. Dart AM, Kingwell BA: Pulse pressure–a review of mechanismsgenesis of atherosclerosis.
and clinical relevance. J Am Coll Cardiol 37:975–984, 2001Age and diabetes mellitus were significant predictors 7. Tozawa M, Iseki K, Iseki C, et al: Analysis of drug prescrip-
of elevated PP in both normal subjects and hemodialysis tion in chronic hemodialysis patients. Nephrol Dial Transplant
17:1819–1824, 2002patients in the present study (Table 2). A loss of compli-
8. Tozawa M, Iseki K, Fukiyama K: Hypertension in dialysis patients:ance in large arteries is associated with aging, and PP A cross-sectional analysis. Nippon Jinzo Gakkai Shi 38:129–135, 1996
increases with age [25]. Diabetes mellitus accelerates the 9. Tozawa M, Oshiro S, Iseki C, et al: Multiple risk factor clus-
tering of hypertension in a screened cohort. J Hypertens 18:1379–decrease in compliance of the vessel [26], and stiffening
1385, 2000of arteries results in increased PP through an increase 10. Tozawa M, Oshiro S, Iseki C, et al: Family history of hyperten-
in both aortic impedance and pulse wave velocity [27]. sion and blood pressure in a screened cohort. Hypertens Res 24:93–
98, 2001The compliance (C) of the arterial wall is simply ex-
11. The Expert Committee on the Diagnosis and Classificationpressed as a function of stroke volume (SV) and PP:
of Diabetes Mellitus: Report of the expert committee on the
C  SV/PP [28, 29]. Decay of compliance, for example, diagnosis and classification of diabetes mellitus. Diabetes Care 20:
1183–1197, 1997with age [25], or an increase of SV, such as in young
12. Iseki K, Tozawa M, Iseki C, et al: Demographic trends in thesubjects [30], results in PP elevation. Arterial stiffness
Okinawa Dialysis Study (OKIDS) registry (1971–2000). Kidney
is worse in hemodialysis patients than in age-matched Int 61:668–675, 2002
13. London GM, Marchais SJ, Safar ME, et al: Aortic and largeoutpatients with normal renal function and the same
artery compliance in end-stage renal failure. Kidney Int 37:137–MAP level [13]. The present study showed that at each
142, 1990
MAP level the PP in hemodialysis patients was higher 14. Asmar R, Vol S, Brisac AM, et al: Reference values for clinic
pulse pressure in a nonselected population. Am J Hypertens 14:415–than that in subjects with normal renal function. These
418, 2001results are consistent with the hypothesis that arterial
15. Cameron JD, Dart AM: Exercise training increases total systemic
stiffening may accelerate in hemodialysis patients [31]. arterial compliance in humans. Am J Physiol 266:H693–H701, 1994
16. McVeigh GE, Brennan GM, Cohn JN, et al: Fish oil improvesIn conclusion, at each MAP level, the PP in hemodialy-
arterial compliance in non-insulin-dependent diabetes mellitus. Ar-sis patients was higher than that in control subjects with-
terioscler Thromb 14:1425–1429, 1994
out renal injury. Higher SBP and lower DBP values 17. Nestel PJ, Yamashita T, Sasahara T, et al: Soy isoflavones im-
prove systemic arterial compliance but not plasma lipids in meno-were observed in hemodialysis patients than in control
pausal and perimenopausal women. Arterioscler Thromb Vasc Biolsubjects. Further study is needed to clarify methods that
17:3392–3398, 1997
reduce PP, and whether treatment that reduces PP im- 18. Safar M, Laurent S, Safavian A, et al: Sodium and large arteries
proves prognosis for hemodialysis patients. in hypertension. Effects of indapamide. Am J Med 84:15–19, 1988
19. Benetos A, Vasmant D, Thiery P, et al: Effects of ramipril on
arterial hemodynamics. J Cardiovasc Pharmacol 18(Suppl 2):S153–
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